S.3094: PRICED Act

About This Bill

  • This bill was introduced in the 114th Congress
  • This bill is primarily about health
  • Introduced June 23, 2016
  • Latest Major Action June 23, 2016

Bill Cosponsor

Bill Summary

Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act This bill amends the Public Health Service Act to allow biosimilars to be marketed seven years after the reference brand name biological product is licensed. Currently, brand name biological products are provided a 12-year marketing exclusivity period. This shortened marketing exclusivity period applies only to biological products licensed by the Food and Drug...

(Source: Library of Congress)

Bill Actions

Date Description
June 23, 2016
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
June 23, 2016

Introduced in the Senate by Sherrod Brown (D-Ohio)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page